186 related articles for article (PubMed ID: 22673088)
21. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins.
Parekh BS; Buchmeier MJ
Virology; 1986 Sep; 153(2):168-78. PubMed ID: 2426862
[TBL] [Abstract][Full Text] [Related]
22. Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
Takayama-Ito M; Lim CK; Yamaguchi Y; Posadas-Herrera G; Kato H; Iizuka I; Islam MT; Morimoto K; Saijo M
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006398. PubMed ID: 29659579
[TBL] [Abstract][Full Text] [Related]
23. Profiling Virus-Specific Tcf1+ T Cell Repertoires During Acute and Chronic Viral Infection.
Yermanos A; Sandu I; Pedrioli A; Borsa M; Wagen F; Oetiker N; Welten SPM; Pallmer K; Reddy ST; Oxenius A
Front Immunol; 2020; 11():986. PubMed ID: 32547546
[TBL] [Abstract][Full Text] [Related]
24. Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection.
Macal M; Lewis GM; Kunz S; Flavell R; Harker JA; Zúñiga EI
Cell Host Microbe; 2012 Jun; 11(6):617-30. PubMed ID: 22704622
[TBL] [Abstract][Full Text] [Related]
25. Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism.
Dylla DE; Xie L; Michele DE; Kunz S; McCray PB
Genet Vaccines Ther; 2011 Apr; 9():8. PubMed ID: 21477292
[TBL] [Abstract][Full Text] [Related]
26. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
Cheng BYH; Nogales A; de la Torre JC; Martínez-Sobrido L
Virology; 2017 Jan; 501():35-46. PubMed ID: 27855284
[TBL] [Abstract][Full Text] [Related]
27. 2-Deoxy-D-glucose inhibits lymphocytic choriomeningitis virus propagation by targeting glycoprotein N-glycosylation.
Baďurová L; Polčicová K; Omasta B; Ovečková I; Kocianová E; Tomášková J
Virol J; 2023 May; 20(1):108. PubMed ID: 37259080
[TBL] [Abstract][Full Text] [Related]
28. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.
Kunz S; Sevilla N; McGavern DB; Campbell KP; Oldstone MB
J Cell Biol; 2001 Oct; 155(2):301-10. PubMed ID: 11604425
[TBL] [Abstract][Full Text] [Related]
30. Interfering with type I interferon: a novel approach to purge persistent viral infection.
Wilson EB; Brooks DG
Cell Cycle; 2013 Sep; 12(18):2919-20. PubMed ID: 23974094
[No Abstract] [Full Text] [Related]
31. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.
Lukashevich IS; Rodas JD; Tikhonov II; Zapata JC; Yang Y; Djavani M; Salvato MS
Arch Virol; 2004 Dec; 149(12):2319-36. PubMed ID: 15338320
[TBL] [Abstract][Full Text] [Related]
32. Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.
Zhang C; Hu B; Xiao L; Liu Y; Wang P
Hum Gene Ther Methods; 2014 Dec; 25(6):328-38. PubMed ID: 25416034
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
de la Torre JC
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
[TBL] [Abstract][Full Text] [Related]
34. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus.
Whitton JL; Southern PJ; Oldstone MB
Virology; 1988 Feb; 162(2):321-7. PubMed ID: 3257596
[TBL] [Abstract][Full Text] [Related]
35. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.
Borrow P; Oldstone MB
J Virol; 1992 Dec; 66(12):7270-81. PubMed ID: 1331520
[TBL] [Abstract][Full Text] [Related]
36. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
[TBL] [Abstract][Full Text] [Related]
37. Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins.
Buchmeier MJ; Southern PJ; Parekh BS; Wooddell MK; Oldstone MB
J Virol; 1987 Apr; 61(4):982-5. PubMed ID: 3546729
[TBL] [Abstract][Full Text] [Related]
38. Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.
Rodas JD; Lukashevich IS; Zapata JC; Cairo C; Tikhonov I; Djavani M; Pauza CD; Salvato MS
J Med Virol; 2004 Mar; 72(3):424-35. PubMed ID: 14748066
[TBL] [Abstract][Full Text] [Related]
39. Novel mechanism of arenavirus-induced liver pathology.
Beier JI; Jokinen JD; Holz GE; Whang PS; Martin AM; Warner NL; Arteel GE; Lukashevich IS
PLoS One; 2015; 10(3):e0122839. PubMed ID: 25822203
[TBL] [Abstract][Full Text] [Related]
40. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
Zeller JC; Nguyen N; Southern PJ
Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
